Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran

Clinical Medicine Insights. Cardiology
Toba KazemiMasood Ziaee

Abstract

Introduction: The alteration in serum lipid profile; increase in total cholesterol (TC), triacylglycerol (TAG), and low-density lipoprotein cholesterol (LDL-C); and reduction in high-density lipoprotein cholesterol (HDL-C) are key factors in cardiovascular disease progression. The high prevalence and severity of cardiovascular diseases require new screening tools for better evaluation. Atherogenic index (AI) (LDL-C/HDL-C) and coronary risk index (CRI) (TC/HDL-C) can be strong markers for predicting the risk of atherosclerosis and coronary heart disease and disclose the presence of LDL or TAG in the serum of related patients. To implement this strategy, the AIs and CRIs in our population were assessed. In this study, a total of 5207 subjects were recruited and AIs and CRIs were calculated for all of them. According to our data, age, body mass index, sex, as well as CRI and AI had affirmative correlation with TC, LDL-C, TAG, systolic blood pressure, and diastolic blood pressure. By increasing these factors, AIs and CRIs were augmented. Moreover, in situations where all atherogenic parameters are normal, these parameters may be the alternative screening tool.

References

Aug 26, 1998·QJM : Monthly Journal of the Association of Physicians·M J LandrayG Y Lip
Jun 17, 2004·Circulation·Rafael CarmenaJean-Charles Fruchart
Apr 21, 2005·Annals of Epidemiology·F BarziUNKNOWN Asia Pacific Cohort Studies Collaboration
Aug 28, 2007·TheScientificWorldJournal·Ying Jiang Obesity Working Group
Dec 19, 2008·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·F HadaeghF Azizi
Jul 17, 2009·Clinics·Angela Bacelar Albuquerque BampiProtásio Lemos da Luz
Sep 26, 2009·Diabetes/metabolism Research and Reviews·Omer T NjajouUNKNOWN Health ABC Study
Aug 29, 2013·Iranian Red Crescent Medical Journal·Mohammad Dehghani FiroozabadiParvaneh Dehghan
Mar 10, 2016·Lipids in Health and Disease·Jobert Richie N NansseuArthur Ketcha

❮ Previous
Next ❯

Citations

Jan 5, 2019·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Samir Helmy Assaad KhalilAlexey V Zilov
Aug 31, 2019·Eating and Weight Disorders : EWD·Sobia Rana, Adil Anwar Bhatti
Aug 30, 2020·Clinical Nutrition ESPEN·Agathi PritsaEvgenia Lymperaki
Jul 9, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tarfa Albrahim, Mona A Alonazi
Oct 26, 2021·Biological Research for Nursing·Ángel Fernández-AparicioEmilio González-Jiménez

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.